Sophie Davies: Patients Often Don’t Consider Supplements to Be ‘Medications’
Sophie Davies, Training and Development Supervisor at Bespoke Clinical Services, shared a post on LinkedIn:
“One observation I’ve made during my experience as a clinical pharmacist is that patients often don’t consider supplements to be ‘medications’, so they don’t always mention them during reviews.
During some anticoagulant safety searches, I identified several patients taking omega-3/cod liver oil supplements alongside DOAC therapy.
They were all unaware of the potential additive bleeding risk.
This reinforced how important clear medicine counselling and thorough medication reviews are in reducing preventable harm.
The goal is to translate guidance into practical, usable information to keep patients fully informed.
Small interventions can have a significant impact on patient safety.”
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 13:29Factor XI Deficiency and the Challenge of Unpredictable Bleeding – EHC
-
Sep 20, 2026, 13:18Cindy Howry: FDA Approves First Treatment for Ataxia-Telangiectasia
-
Sep 20, 2026, 13:08Mohammad Salar Amoli: When Routine Coagulation Tests Miss von Willebrand Disease
-
Sep 20, 2026, 12:55Stelios Andreadis։ Human Salivary Gland Organoids Offer New Potential for Regenerative Medicine
-
Sep 20, 2026, 12:43Obi Light Ogbonnia: The Power of Lived Experience in Sickle Cell Care
-
Sep 20, 2026, 12:34Sabrine Mekni: Advancing HSCT for Children With Fanconi Anemia
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI